Association of circulating TNF-α and IL-6 with ageing and parkinsonism

被引:267
作者
Dobbs, RJ [1 ]
Charlett, A
Purkiss, AG
Dobbs, SM
Weller, C
Peterson, DW
机构
[1] Univ Hertfordshire, Div Biosci, Res Grp, Hatfield AL10 9AB, Herts, England
[2] Publ Hlth Lab Serv, Stat Unit, London, England
[3] Hillingdon Hosp, Postgrad & Res Ctr, Res Grp, Uxbridge, Middx, England
来源
ACTA NEUROLOGICA SCANDINAVICA | 1999年 / 100卷 / 01期
关键词
cytokines; circulating TNF-alpha and IL-6; ageing; idiopathic parkinsonism; quantification of facets; inflammation immunity; environmental insult; aetiology;
D O I
10.1111/j.1600-0404.1999.tb00721.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction - We propose that the increase in TNF-alpha and IL-6 in the brain in idiopathic parkinsonism is in response to a peripheral immune/ inflammatory process, so ubiquitous as to be responsible for the resemblance between ageing and parkinsonism. Methods - Circulating cytokine was measured in 78 subjects with idiopathic parkinsonism and 140 without, aged 30 to 90 years, all obeying inclusion/exclusion criteria. Results - Serum TNF-alpha increased (P<0.0001) by 1.37 (95% CI 0.75, 2.00) %.y(-1), IL-6 by 2.63 (1.75, 3.52) (P<0.0005). TNF-alpha appeared elevated in parkinsonians whose postural and psychomotor responses were abnormal, being suppressed where they were normal: trends which contrasted with those in controls (P=0.015 and 0.05, respectively). Parkinsonism appeared (P=0.08) to have an effect on IL-6, equivalent to that of >10 years of ageing (28(-3, 69)%), but was not immediately related to between-subject differences in performance. Conclusion - Ageing and pathogenetic insult may be confounded, age being a progression, not a risk, factor.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 71 条
[1]
[Anonymous], EUR J CLIN PHARM S
[2]
AGING AND EXTRAPYRAMIDAL SYSTEM [J].
BARBEAU, A .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1973, 21 (04) :145-149
[3]
Properties of sufficiency and statistical tests [J].
Bartlett, MS .
PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL AND PHYSICAL SCIENCES, 1937, 160 (A901) :0268-0282
[4]
Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151
[5]
INCREASED PRODUCTION OF TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-6 BY ARTERIAL-WALL OF AGED RATS [J].
BELMIN, J ;
BERNARD, C ;
CORMAN, B ;
MERVAL, R ;
ESPOSITO, B ;
TEDGUI, A .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (06) :H2288-H2293
[6]
BIRKMAYER W, 1980, PARKINSONS DIS BIOCH, P22
[7]
IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE [J].
BOKA, G ;
ANGLADE, P ;
WALLACH, D ;
JAVOYAGID, F ;
AGID, Y ;
HIRSCH, EC .
NEUROSCIENCE LETTERS, 1994, 172 (1-2) :151-154
[8]
OBJECTIVE EVIDENCE FOR TOLERANCE, AGAINST A BACKGROUND OF IMPROVEMENT, DURING MAINTENANCE THERAPY WITH CONTROLLED RELEASE LEVODOPA CARBIDOPA [J].
BOWES, SG ;
DOBBS, RJ ;
HENLEY, M ;
CHARLETT, A ;
ONEILL, CJA ;
NICHOLSON, PW ;
PURKISS, AG ;
WELLER, C ;
DOBBS, SM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (05) :483-489
[9]
OBJECTIVE OUTCOME CRITERIA IN TRIALS OF ANTI-PARKINSONIAN THERAPY IN THE ELDERLY - SENSITIVITY, SPECIFICITY AND RELIABILITY OF MEASURES OF BRADYKINESIA AND HYPOKINESIA [J].
BOWES, SG ;
CLARK, PK ;
CHARLETT, A ;
ONEILL, CJA ;
LEEMAN, AL ;
WELLER, C ;
NICHOLSON, PW ;
DESHMUKH, AA ;
DOBBS, SM ;
DOBBS, RJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (03) :295-304
[10]
BOWES SG, 1992, SCAND J REHABIL MED, V24, P181